Paul A van der Zwaag

6PUBLICATIONS
36CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedBiomechanicsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersArchival, repository and related studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2025
Multigene panel analysis has limited additional value compared to transthyretin gene analysis in Dutch patients with suspected cardiac amyloidosis.

Milou Berends, Hendrea S A Tingen, Johan Bijzet

|Aug 08, 2024
[99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients.

Hendrea Sanne Aletta Tingen, Dion Groothof, Alwin Tubben

|Apr 01, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.

Myrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint

|Oct 16, 2023
Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?

H S A Tingen, A Tubben, J Bijzet

|Jun 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.

Tom E Verstraelen, Freyja H M van Lint, Laurens P Bosman

|Nov 15, 2019
Coexistence of wild type and hereditary ATTR amyloidosis in one family.

Josine G Feenstra, Hans L A Nienhuis, Johan Bijzet

Pageof 1

Frequent Collaborators

4 joint publications

Johan Bijzet

4 joint publications

Hans L A Nienhuis

4 joint publications

Bouke P C Hazenberg

3 joint publications

Hendrea Sanne Aletta Tingen